Company intelligence / Profile preview

XingImaging

New Haven, Connecticut, United Statesxingimaging.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

XingImaging provides end-to-end support for radiopharmaceutical imaging trials, including radioligand development/production, design/implementation of clinical imaging trials using PET/SPECT, and multi-center trial management. The company has leadership roles in numerous clinical imaging trials focused on advancing diagnostics and therapeutics for CNS diseases. No proprietary therapeutic programs or direct clinical results reported as it operates primarily as a CRO/CDMO/service provider.

Therapeutic areas: OncologyNeurology
Modalities: RadiopharmaceuticalsRadioligandsSmall moleculeDevice
Industry: Contract Research Organization

Partnerships

MITRO Biotech Co., Ltd.Pharmaceutical/biotech companies running CNS imaging studies

Beyond the preview

Go deeper on XingImaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XingImaging.

Explore the full profile